The antimycotic ciclopirox olamine induces HIF‐1α stability, VEGF expression, and angiogenesis
0301 basic medicine
1303 Biochemistry
Antifungal Agents
Iron
CHO Cells
Chick Embryo
Endothelial Growth Factors
Deferoxamine
In Vitro Techniques
Kidney
Binding, Competitive
10052 Institute of Physiology
03 medical and health sciences
2,2'-Dipyridyl
1311 Genetics
Allantois
Cricetinae
1312 Molecular Biology
Animals
Luciferases
Binding Sites
Chorion
Ciclopirox
Hypoxia-Inducible Factor 1, alpha Subunit
Gene Expression Regulation
1305 Biotechnology
570 Life sciences; biology
Intercellular Signaling Peptides and Proteins
DOI:
10.1096/fj.02-0586fje
Publication Date:
2003-03-29T02:03:22Z
AUTHORS (6)
ABSTRACT
The heterodimeric hypoxia-inducible factor (HIF)-1 is a master regulator of oxygen homeostasis. Protein stability and transactivation function the α subunit are controlled by iron- oxygen-dependent hydroxylation proline asparagine residues. anti-mycotic ciclopirox olamine (CPX) lipophilic bidentate iron chelator that stabilizes HIF-1α under normoxic conditions at lower concentrations than other chelators, probably inhibiting hydroxylation. As shown inhibition iron-dependent quenching FITC-labeled deferoxamine (DFX) fluorescence, CPX appears to have an even higher affinity for DFX. Initial observations treatment with 1% CPX, but not placebo, occasionally caused reddening wound margins in mouse skin model prompted us investigate capability induce angiogenesis. CPX-induced HIF-1-mediated reporter gene activity endogenous HIF-1 target expression, including elevation transcription, mRNA, protein levels vascular endothelial growth (VEGF). In chick chorioallantoic membrane assay, inert polymer disks containing solvent alone induced summary, these results suggest induces angiogenesis vivo via VEGF induction. Therefore, might serve as alternative recombinant or therapy therapeutic
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (60)
CITATIONS (78)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....